Publications (234)

2022

  1. Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1

    Journal of Personalized Medicine, Vol. 12, Núm. 5

  2. Molecular diagnosis in non-small-cell lung cancer: Expert opinion on ALK and ROS1 testing

    Journal of Clinical Pathology, Vol. 75, Núm. 3, pp. 145-153

  3. Re: Epigenomic and Transcriptional Profiling Identifies Impaired Glyoxylate Detoxification in NAFLD as a Risk Factor for Hyperoxaluria

    Journal of Urology

  4. New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production

    European Journal of Medicinal Chemistry, Vol. 237

  5. In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria

    Molecular Therapy - Methods and Clinical Development, Vol. 25, pp. 137-146

  6. Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry

    Kidney International Reports, Vol. 7, Núm. 7, pp. 1608-1618

  7. Allosteric Communication in the Multifunctional and Redox NQO1 Protein Studied by Cavity‐Making Mutations

    Antioxidants, Vol. 11, Núm. 6

2021

  1. Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31

  2. Hiperoxalurias. Oxalosis

    Nefrología pediátrica (Ediciones de la Universidad de Oviedo), pp. 1011-1020

  3. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

  4. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients

    Biochemical and Biophysical Research Communications, Vol. 543, pp. 45-49

  5. Structural basis of the pleiotropic and specific phenotypic consequences of missense mutations in the multifunctional NAD(P)H:quinone oxidoreductase 1 and their pharmacological rescue

    Redox Biology, Vol. 46

  6. High Expression of FOXP2 Is Associated with Worse Prognosis in Glioblastoma

    World Neurosurgery, Vol. 150, pp. e253-e278

  7. Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria

    Cell Reports, Vol. 36, Núm. 8

  8. ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

    Oncogene, Vol. 40, Núm. 16, pp. 2923-2935

2020

  1. Prevalence and genotype distribution of cervical human papilomavirus infection in the pre-vaccination era: A population-based study in the Canary Islands

    BMJ Open, Vol. 10, Núm. 9

  2. Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice

    Frontiers in Medicine, Vol. 7

  3. Naturally-occurring rare mutations cause mild to catastrophic effects in the multifunctional and cancer-associated NQO1 protein

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-31

  4. Gastric metastases with a choriocarcinoma component from a postpuberal teratoma with mature histology

    Revista Espanola de Patologia

  5. Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells

    Carcinogenesis, Vol. 41, Núm. 8, pp. 1113-1122